Jennifer A. Sealey-Voyksner
Direttore Tecnico/Scientifico/R&S presso ENTERO THERAPEUTICS, INC.
Profilo
Jennifer A.
Sealey-Voyksner is the founder of ImmunogenX, Inc., a company founded in 2013.
She held the title of Director & Chief Scientific Officer from 2013 to 2024.
Currently, Dr. Sealey-Voyksner is the Vice President-Research & Development at First Wave Biopharma, Inc., starting in 2024.
Posizioni attive di Jennifer A. Sealey-Voyksner
| Società | Posizione | Inizio |
|---|---|---|
| ENTERO THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 13/03/2024 |
Precedenti posizioni note di Jennifer A. Sealey-Voyksner
| Società | Posizione | Fine |
|---|---|---|
ImmunogenX LLC
 ImmunogenX LLC BiotechnologyHealth Technology ImmunogenX LLC develops diagnosis and treatment for autoimmune and gastrointestinal diseases. It focuses on therapy, disease management, and food safety. The company was founded by Jack A. Syage and Jennifer A. Sealey-Voyksner in 2013 and is headquartered in Newport Beach, CA. | Fondatore | 13/03/2024 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ENTERO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
ImmunogenX LLC
ImmunogenX LLC BiotechnologyHealth Technology ImmunogenX LLC develops diagnosis and treatment for autoimmune and gastrointestinal diseases. It focuses on therapy, disease management, and food safety. The company was founded by Jack A. Syage and Jennifer A. Sealey-Voyksner in 2013 and is headquartered in Newport Beach, CA. | Health Technology |
- Borsa valori
- Insiders
- Jennifer A. Sealey-Voyksner
